| Name | Sakrx Llc |
|---|---|
| Organization Name | Sakrx Llc |
| Location | 403 Main St, Malvern, Iowa 51551 |
| Type | Long Term Care Pharmacy |
| Phone | (712) 624-9036 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
The U.S. Food and Drug Administration (FDA) is currently working with five states and the Centers for Disease Control and Prevention to investigate an outbreak of norovirus which has been associated with raw, frozen oysters on the half shell from South Korea.
Despite the high prevalence of mental illness, and high rates of suicide among young Australians, more than half (54%) of all people with mental health issues do not seek help.
A partnership between Aston University scientists and industry partners has led to the rapid launch of a range of alcohol-free sanitiser products to combat Covid-19.
A new study from the Indiana University School of Medicine and the Regenstrief Institute has found that Black and especially Hispanic young women are screened for chlamydia at a significantly higher rate than young white women. This discrepancy in screening rates may contribute to nationwide reporting of higher rates of this sexually transmitted disease among minority young women.
› Verified 5 days ago
| NPI Number | 1376166306 |
| Organization Name | SAKRX, LLC |
| Type | Long Term Care Pharmacy |
| Address | 403 Main St, Malvern, IA 51551 |
| Phone Number | 712-624-9036 |
News Archive
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
The U.S. Food and Drug Administration (FDA) is currently working with five states and the Centers for Disease Control and Prevention to investigate an outbreak of norovirus which has been associated with raw, frozen oysters on the half shell from South Korea.
Despite the high prevalence of mental illness, and high rates of suicide among young Australians, more than half (54%) of all people with mental health issues do not seek help.
A partnership between Aston University scientists and industry partners has led to the rapid launch of a range of alcohol-free sanitiser products to combat Covid-19.
A new study from the Indiana University School of Medicine and the Regenstrief Institute has found that Black and especially Hispanic young women are screened for chlamydia at a significantly higher rate than young white women. This discrepancy in screening rates may contribute to nationwide reporting of higher rates of this sexually transmitted disease among minority young women.
› Verified 5 days ago
News Archive
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
The U.S. Food and Drug Administration (FDA) is currently working with five states and the Centers for Disease Control and Prevention to investigate an outbreak of norovirus which has been associated with raw, frozen oysters on the half shell from South Korea.
Despite the high prevalence of mental illness, and high rates of suicide among young Australians, more than half (54%) of all people with mental health issues do not seek help.
A partnership between Aston University scientists and industry partners has led to the rapid launch of a range of alcohol-free sanitiser products to combat Covid-19.
A new study from the Indiana University School of Medicine and the Regenstrief Institute has found that Black and especially Hispanic young women are screened for chlamydia at a significantly higher rate than young white women. This discrepancy in screening rates may contribute to nationwide reporting of higher rates of this sexually transmitted disease among minority young women.
› Verified 5 days ago
Sakrx Llc Type: Long Term Care Pharmacy Location: 403 Main St, Malvern, Iowa 51551 Phone: (712) 624-9036 |